The Impact of the Myeloid Response to Radiation Therapy

Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby as...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael J. Gough, Kristina Young, Marka Crittenden
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/281958
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549084039217152
author Michael J. Gough
Kristina Young
Marka Crittenden
author_facet Michael J. Gough
Kristina Young
Marka Crittenden
author_sort Michael J. Gough
collection DOAJ
description Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby assisting multiple critical checkpoints in antitumor adaptive immunity. Adaptive immunity is terminated by inflammatory resolution, an active process which ensures that inflammatory damage is repaired and tissue function is restored. We discuss how radiation therapy similarly triggers inflammation followed by repair, the consequences to adaptive immune responses in the treatment site, and how the myeloid response to radiation may impact immunotherapies designed to improve control of residual cancer cells.
format Article
id doaj-art-2e2e4ce7ecbe45038f624d5ae6e0d2c9
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-2e2e4ce7ecbe45038f624d5ae6e0d2c92025-02-03T06:12:14ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/281958281958The Impact of the Myeloid Response to Radiation TherapyMichael J. Gough0Kristina Young1Marka Crittenden2Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, 4805 NE Glisan, Portland, OR 97213, USAThe Department of Radiation Medicine, Oregon Health & Science University, Portland, OR 97239, USAEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, 4805 NE Glisan, Portland, OR 97213, USARadiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby assisting multiple critical checkpoints in antitumor adaptive immunity. Adaptive immunity is terminated by inflammatory resolution, an active process which ensures that inflammatory damage is repaired and tissue function is restored. We discuss how radiation therapy similarly triggers inflammation followed by repair, the consequences to adaptive immune responses in the treatment site, and how the myeloid response to radiation may impact immunotherapies designed to improve control of residual cancer cells.http://dx.doi.org/10.1155/2013/281958
spellingShingle Michael J. Gough
Kristina Young
Marka Crittenden
The Impact of the Myeloid Response to Radiation Therapy
Clinical and Developmental Immunology
title The Impact of the Myeloid Response to Radiation Therapy
title_full The Impact of the Myeloid Response to Radiation Therapy
title_fullStr The Impact of the Myeloid Response to Radiation Therapy
title_full_unstemmed The Impact of the Myeloid Response to Radiation Therapy
title_short The Impact of the Myeloid Response to Radiation Therapy
title_sort impact of the myeloid response to radiation therapy
url http://dx.doi.org/10.1155/2013/281958
work_keys_str_mv AT michaeljgough theimpactofthemyeloidresponsetoradiationtherapy
AT kristinayoung theimpactofthemyeloidresponsetoradiationtherapy
AT markacrittenden theimpactofthemyeloidresponsetoradiationtherapy
AT michaeljgough impactofthemyeloidresponsetoradiationtherapy
AT kristinayoung impactofthemyeloidresponsetoradiationtherapy
AT markacrittenden impactofthemyeloidresponsetoradiationtherapy